Enfusion Stock Return On Equity
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Enfusion's long-term financial health and intrinsic value.
Enfusion |
Enfusion Company Return On Equity Analysis
Enfusion's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Enfusion Return On Equity | 0.0442 |
Most of Enfusion's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enfusion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Enfusion has a Return On Equity of 0.0442. This is 100.37% lower than that of the Software sector and significantly higher than that of the Information Technology industry. The return on equity for all United States stocks is 114.26% lower than that of the firm.
Enfusion Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enfusion's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Enfusion could also be used in its relative valuation, which is a method of valuing Enfusion by comparing valuation metrics of similar companies.Enfusion is currently under evaluation in return on equity category among its peers.
Enfusion Fundamentals
| Return On Equity | 0.0442 | |||
| Return On Asset | 0.0305 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.01 B | |||
| Shares Outstanding | 94.8 M | |||
| Shares Owned By Insiders | 4.73 % | |||
| Shares Owned By Institutions | 96.25 % | |||
| Number Of Shares Shorted | 1.3 M | |||
| Price To Earning | 0.11 X | |||
| Price To Book | 13.93 X | |||
| Price To Sales | 5.06 X | |||
| Revenue | 201.61 M | |||
| Gross Profit | 136.74 M | |||
| EBITDA | 6.16 M | |||
| Net Income | 3.92 M | |||
| Cash And Equivalents | 56.56 M | |||
| Cash Per Share | 0.84 X | |||
| Total Debt | 20.31 M | |||
| Current Ratio | 9.17 X | |||
| Book Value Per Share | 0.77 X | |||
| Cash Flow From Operations | 34.68 M | |||
| Short Ratio | 1.46 X | |||
| Earnings Per Share | 0.03 X | |||
| Price To Earnings To Growth | 2.35 X | |||
| Target Price | 11.25 | |||
| Number Of Employees | 1.14 K | |||
| Beta | 0.93 | |||
| Market Capitalization | 1.02 B | |||
| Total Asset | 143.26 M | |||
| Retained Earnings | (170.11 M) | |||
| Working Capital | 66.19 M | |||
| Net Asset | 143.26 M |
About Enfusion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enfusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enfusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enfusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |